🇺🇸 FDA
Patent

US 10960079

Conjugates of an IL-2 moiety and a polymer

granted A61KA61K38/2013A61K47/60

Quick answer

US patent 10960079 (Conjugates of an IL-2 moiety and a polymer) held by Nektar Therapeutics expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/2013, A61K47/60, A61P, A61P17/00